In the BioHarmony Drug Report Database
Valganciclovir
Valcyte (valganciclovir) is a small molecule pharmaceutical. Valganciclovir was first approved as Valcyte on 2001-03-29. It is used to treat aids-related opportunistic infections, cytomegalovirus infections, and cytomegalovirus retinitis in the USA. Valcyte’s patent is valid until 2027-12-11 (FDA).
Trade Name
|
Valcyte |
|---|---|
Common Name
|
valganciclovir |
ChEMBL ID
|
CHEMBL1201314 |
Indication
|
aids-related opportunistic infections, cytomegalovirus infections, cytomegalovirus retinitis |
Drug Class
|
Antivirals: antivirals (acyclovir type) |
Image (chem structure or protein)